US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avon

5.60

0.0000

Volume:- -

Turnover:- -

Market Cap:2.48B

PE:-48.65

High:5.60

Open:5.60

Low:5.60

Close:5.60

52wk High:5.92

52wk Low:1.59

Shares:443.53M

Float Shares:378.82M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1151

EPS(LYR):-0.0987

ROE:-1.62%

ROA:6.61%

PB:-2.75

PE(LYR):-56.76

Loading ...

Overview Company News Filings

Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

Avon Technologies Delivers Profits Surge In Latest Call

Avon Technologies Reports Strong First-Half Performance with EPS of 56 Cents

Avon Technologies: Buy Rating Reiterated on Strong 1H26 Performance and Outlook; $2,330 Price Target Unchanged

Avon Technologies Beats Profit Targets Early as Defence Demand Surges

Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology

Barclays Reaffirms Their Hold Rating on Avon Technologies (AVON)

Avon Technologies Executives Add Shares Through Incentive Plan

Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference

Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society

Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity

LifeVantage Appointing Terrence Moorehead as Chief Executive Officer

AV Production uses Sennheiser Spectera to bring control and clarity to touring

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Avon Technologies Executives Add Shares Through Employee Incentive Plan

Japfa Food Indonesia Transforms Supply Chain Planning with RELEX

Rhythm Pharmaceuticals Announces Changes to Board of Directors

Avon Technologies Discloses CEO’s Nil-Cost Share Transfer to Spouse

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVP\",,,,,undefined,":{"symbol":"AVP","market":"US","secType":"STK","nameCN":"Avon","latestPrice":5.6,"timestamp":1578085200000,"preClose":5.6,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":378820896,"shares":443525346,"eps":-0.115112,"marketStatus":"Delisted","change":0,"latestTime":"05-28 14:29:41 EDT","open":5.6,"high":5.6,"low":5.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.115112,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779998400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-179866800000,"exchange":"NYSE","adjPreClose":5.6,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVP\",,,,,undefined,":{"symbol":"AVP","floatShares":378820896,"roa":"6.61%","roe":"-1.62%","lyrEps":-0.098664,"shares":443525346,"dividePrice":0,"high":5.6,"amplitude":0,"preClose":5.6,"low":5.6,"week52Low":1.59,"pbRate":"-2.75","week52High":5.92,"institutionHeld":0.685,"latestPrice":5.6,"eps":-0.115112,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.115112,"open":5.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-12-27","symbol":"AVP","amount":0.0160442,"name":"雅芳","payableDate":"2019-12-30","currency":"USD","type":"dividend","dateTimestamp":1577422800000},{"date":"2019-10-31","symbol":"AVP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":0.03,"defaultRemindTime":1572508800000,"name":null,"time":"Pre-Market","dateTimestamp":1572494400000,"actualEps":null},{"date":"2019-08-01","symbol":"AVP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":0.04,"defaultRemindTime":1564646400000,"name":null,"time":"Pre-Market","dateTimestamp":1564632000000,"actualEps":-0.03},{"market":"US","date":"2019-05-02","symbol":"AVP","fiscalQuarterEnding":"2019/03","expectedEps":-0.01,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1556769600000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2019-02-14","symbol":"AVP","fiscalQuarterEnding":"2018/12","expectedEps":0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1550120400000,"reportTimeType":"pre","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVP\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":null,"value":0.0160442,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638698175","title":"Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698175","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698175?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969600,"startTime":"0","endTime":"0","summary":"BOSTON, May  28, 2026  (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ra","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302763/0/en/Rhythm-Pharmaceuticals-Announces-Publication-of-New-Bardet-Biedl-Syndrome-Diagnostic-Algorithm-in-the-American-Journal-of-Medical-Genetics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4201","BK4107","AFG","AVP","BK4117","ENDO","EC","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638514825","title":"Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2638514825","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638514825?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:00","pubTimestamp":1779796800,"startTime":"0","endTime":"0","summary":"BOSTON, May  26, 2026  (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/26/3300998/0/en/Rhythm-Pharmaceuticals-Announces-Participation-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","BK4201","AVP","EC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636158268","title":"Avon Technologies Delivers Profits Surge In Latest Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2636158268","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636158268?lang=en_us&edition=fundamental","pubTime":"2026-05-20 14:15","pubTimestamp":1779257737,"startTime":"0","endTime":"0","summary":"Avon Technologies plc (($GB:AVON)) has held its Q2 earnings call. Read on for the main highlights of the call. Avon Technologies’ latest earnings c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-delivers-profits-surge-in-latest-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-delivers-profits-surge-in-latest-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143970695","title":"Avon Technologies Reports Strong First-Half Performance with EPS of 56 Cents","url":"https://stock-news.laohu8.com/highlight/detail?id=1143970695","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143970695?lang=en_us&edition=fundamental","pubTime":"2026-05-14 03:22","pubTimestamp":1778700163,"startTime":"0","endTime":"0","summary":"UK-based military protective equipment manufacturer Avon Technologies Plc announced its financial results for the first half of fiscal year 2026 on Wednesday, reporting non-GAAP earnings per share of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635496205","title":"Avon Technologies: Buy Rating Reiterated on Strong 1H26 Performance and Outlook; $2,330 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2635496205","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635496205?lang=en_us&edition=fundamental","pubTime":"2026-05-13 15:15","pubTimestamp":1778656522,"startTime":"0","endTime":"0","summary":"Analyst Andrew Douglas from Jefferies maintained a Buy rating on Avon Technologies and keeping the price target at p2,330.00. Andrew Douglas has gi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/avon-technologies-buy-rating-reiterated-on-strong-1h26-performance-and-outlook-2330-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/avon-technologies-buy-rating-reiterated-on-strong-1h26-performance-and-outlook-2330-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635220837","title":"Avon Technologies Beats Profit Targets Early as Defence Demand Surges","url":"https://stock-news.laohu8.com/highlight/detail?id=2635220837","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635220837?lang=en_us&edition=fundamental","pubTime":"2026-05-13 14:31","pubTimestamp":1778653901,"startTime":"0","endTime":"0","summary":"An announcement from Avon Technologies ( ($GB:AVON) ) is now available. Avon Technologies reported a strong first half to fiscal 2026, with revenue...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-beats-profit-targets-early-as-defence-demand-surges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-beats-profit-targets-early-as-defence-demand-surges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634219760","title":"Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology","url":"https://stock-news.laohu8.com/highlight/detail?id=2634219760","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634219760?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:00","pubTimestamp":1778587200,"startTime":"0","endTime":"0","summary":"– Real world data showed clinically meaningful BMI reductions with setmelanotide in 62 adults with 12-month data living with acquired hypothalamic obesity (HO) in France – – Phase 3 analyses demonstra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292752/0/en/Rhythm-Pharmaceuticals-Announces-New-Data-Presentations-at-the-2026-European-Congress-of-Endocrinology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","CP","LU1261432733.SGD","LU1989763690.USD","BK4201","BK4585","BK4016","EPV","AVP","EC","LU1989763427.SGD","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634826402","title":"Barclays Reaffirms Their Hold Rating on Avon Technologies (AVON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634826402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634826402?lang=en_us&edition=fundamental","pubTime":"2026-05-12 14:17","pubTimestamp":1778566625,"startTime":"0","endTime":"0","summary":"Barclays analyst Milene Kerner maintained a Hold rating on Avon Technologies yesterday. The company’s shares closed yesterday at p1,652.00. Accordi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-reaffirms-their-hold-rating-on-avon-technologies-avon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-reaffirms-their-hold-rating-on-avon-technologies-avon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633136111","title":"Avon Technologies Executives Add Shares Through Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2633136111","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633136111?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:12","pubTimestamp":1778073139,"startTime":"0","endTime":"0","summary":"An update from Avon Technologies ( ($GB:AVON) ) is now available. Avon Technologies has disclosed routine share purchases by its chief executive of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-add-shares-through-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-add-shares-through-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633013363","title":"Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2633013363","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633013363?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:00","pubTimestamp":1778068800,"startTime":"0","endTime":"0","summary":"BOSTON, May  06, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288752/0/en/Rhythm-Pharmaceuticals-Announces-Participation-in-Upcoming-Bank-of-America-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LU1880398471.USD","EC","LU0149725797.USD","LABU","LU0417517546.SGD","LU2129689514.USD","IE0034235188.USD","LU0053666078.USD","LU1894683348.USD","LU1496350502.SGD","LU0128525689.USD","LU1804176565.USD","AVP","LU0477156797.USD","LU1069347547.HKD","LU2265009873.SGD","LU0234570918.USD","LU0306807586.USD","IE00BLSP4452.SGD","LU0787776722.HKD","LU1162221912.USD","LU0648001328.SGD","IE00BLSP4239.USD","LU1668664300.SGD","VUS","HCSG","BK4201","PGF","IE0002270589.USD","LU0310800965.SGD","LU0314106906.USD","LU0640476718.USD","XBI","BAC","LU0052756011.USD","LU2129689431.USD","LU0477156953.USD","LU0130103400.USD","BK4207","LU1363072403.SGD","LU0234572021.USD","LU0256863811.USD","LU0211331839.USD","LU0321505439.SGD","LU1883839398.USD","LU0128526141.USD","BK4534","LU0130102774.USD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632958408","title":"Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society","url":"https://stock-news.laohu8.com/highlight/detail?id=2632958408","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632958408?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:00","pubTimestamp":1777896000,"startTime":"0","endTime":"0","summary":"-- Pediatric patients (n=10) with acquired hypothalamic obesity achieved sustained reductions in BMI and BMI-Z at 2.5 years of setmelanotide therapy ---- Weight category improvements observed in pedia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3286656/0/en/Rhythm-Pharmaceuticals-Announces-New-Data-Presentations-in-Acquired-Hypothalamic-Obesity-at-Pediatric-Endocrine-Society.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","AVP","BK4201","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632861999","title":"Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2632861999","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632861999?lang=en_us&edition=fundamental","pubTime":"2026-05-01 18:55","pubTimestamp":1777632900,"startTime":"0","endTime":"0","summary":"-- First therapy to be FDA-approved and EC-authorized for acquired hypothalamic obesity -- -- European Commission grants authorization in adults and children 4 years of age and above with acquired hyp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/01/3285813/0/en/Rhythm-Pharmaceuticals-Announces-IMCIVREE-Setmelanotide-Granted-Marketing-Authorization-by-European-Commission-for-the-Treatment-of-Obesity-and-Control-of-Hunger-in-Patients-with-A.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP","BK4201","BMI","BK4157","EC","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628448632","title":"LifeVantage Appointing Terrence Moorehead as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628448632","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628448632?lang=en_us&edition=fundamental","pubTime":"2026-04-17 05:15","pubTimestamp":1776374100,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, April  16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate op","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/16/3275871/17697/en/LifeVantage-Appointing-Terrence-Moorehead-as-Chief-Executive-Officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627485823","title":"AV Production uses Sennheiser Spectera to bring control and clarity to touring","url":"https://stock-news.laohu8.com/highlight/detail?id=2627485823","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627485823?lang=en_us&edition=fundamental","pubTime":"2026-04-13 11:00","pubTimestamp":1776049200,"startTime":"0","endTime":"0","summary":"SINGAPORE, April 13, 2026 /PRNewswire/ -- Singapore-basedAV Production  is a production house specialising in concert productions and festivals. Beyond event services, AVP's founder, Favian Ngan, is also an active touring monitor engineer and works with many leading Asian artists. This dual role gives Favian a unique perspective, balancing long-term system design with the fast-paced demands of large-scale live touring.Favian Ngan, founder of AV Production and touring monitor engineer. Favian first deployed Spectera at a major stop on the tour as part of the Sennheiser Spectera Pioneer Programme. Favian currently runs 22 Spectera bodypacks on two Base Stations.  Darryl Tan, Business Development Manager at Sennheiser Asia, Favian Ngan, Founder of AV Production, and Gerald Fong, Projects and Sales Director at Concept Systems during the Singapore stop of an international world tour held at the Singapore Indoor Stadium","market":"us","thumbnail":"https://mma.prnewswire.com/media/2953722/image1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2953722/image1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/av-production-uses-sennheiser-spectera-to-bring-control-and-clarity-to-touring-302740057.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626718729","title":"Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626718729","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626718729?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:00","pubTimestamp":1775736000,"startTime":"0","endTime":"0","summary":"BOSTON, April  09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3270878/0/en/Rhythm-Pharmaceuticals-to-Report-First-Quarter-2026-Financial-Results-on-Tuesday-May-5-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","EC","BK4201","AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625943889","title":"Avon Technologies Executives Add Shares Through Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2625943889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625943889?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:57","pubTimestamp":1775645850,"startTime":"0","endTime":"0","summary":"Avon Technologies ( ($GB:AVON) ) has issued an announcement. Avon Technologies plc disclosed that its chief executive officer Jos Sclater and chief...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-add-shares-through-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-add-shares-through-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625931214","title":"Japfa Food Indonesia Transforms Supply Chain Planning with RELEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2625931214","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625931214?lang=en_us&edition=fundamental","pubTime":"2026-04-07 17:59","pubTimestamp":1775555940,"startTime":"0","endTime":"0","summary":"Asian protein producer goes live across nine plants, expands rollout to increase margins and improve operational control. With RELEX,Japfa Food Indonesia is implementing demand planning, master planning, distribution planning, and inventory planning within a unified platform. The solution supports more accurate short- and long-term forecasting using machine learning, aligns production and cut planning with real demand, and improves visibility across plants and distribution centers.In the first phase, RELEX supports planning acrossJapfaFood Indonesia's live bird operations, including optimizing cut plans to better match supply with customer demand and reduce surplus. By aligning demand, production,distribution,and inventory planning,Japfa Food Indonesia aims to improve delivery service, reduce margin erosion, and limit manual intervention in daily planning processes.From the second half of 2026,JapfaFood Indonesiawill expand the implementation to its further processing division, coverin","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2856814/RELEX_Solutions_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2856814/RELEX_Solutions_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/japfa-food-indonesia-transforms-supply-chain-planning-with-relex-302735600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624650779","title":"Rhythm Pharmaceuticals Announces Changes to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2624650779","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624650779?lang=en_us&edition=fundamental","pubTime":"2026-04-03 21:00","pubTimestamp":1775221200,"startTime":"0","endTime":"0","summary":"-- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April  03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/03/3268007/0/en/Rhythm-Pharmaceuticals-Announces-Changes-to-Board-of-Directors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","BK4201","AVP","EC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622220798","title":"Avon Technologies Discloses CEO’s Nil-Cost Share Transfer to Spouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2622220798","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622220798?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:34","pubTimestamp":1774618485,"startTime":"0","endTime":"0","summary":"Avon Technologies ( ($GB:AVON) ) has issued an update. Avon Technologies has disclosed an internal share transfer involving its chief executive off...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-discloses-ceos-nil-cost-share-transfer-to-spouse?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-discloses-ceos-nil-cost-share-transfer-to-spouse?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622868600","title":"Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment","url":"https://stock-news.laohu8.com/highlight/detail?id=2622868600","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622868600?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:01","pubTimestamp":1774530060,"startTime":"0","endTime":"0","summary":"-- European Commission decision anticipated in second quarter of 2026 -- BOSTON, March  26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3263104/0/en/Rhythm-Pharmaceuticals-Receives-Positive-CHMP-Opinion-for-IMCIVREE-setmelanotide-for-the-Treatment-of-Obesity-and-Control-of-Hunger-in-Patients-with-Acquired-Hypothalamic-Obesity-d.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","CHMP","EMA","EC","VUS","BK4081","AVP","BK4201"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}